Quetiapine lowers sympathetic and hyperthermic reactions due to cerebral injection of orexin A

Neuropeptides

Volumn 40, Issue 5, 2006, Pages 357-363

  Monda, M ^a   Viggiano, An ^a   Viggiano, Al ^a   Viggiano, E ^a   Messina, G ^a   Tafuri, D ^b   De Luca, V ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b University of Naples   (Italy)

Author keywords

Body temperature; Orexin A; Quetiapine; Rat; Sympathetic activity

Indexed keywords

OREXIN A; QUETIAPINE; SODIUM CHLORIDE; URETHAN;

ADRENERGIC SYSTEM; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; BRAIN VENTRICLE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HEART RATE; HYPERTHERMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; STATISTICAL ANALYSIS; SYMPATHETIC NERVE; SYMPATHETIC TONE; THERMOGENESIS AND THERMOREGULATION;

ADIPOSE TISSUE, BROWN; ANIMALS; ANTIPSYCHOTIC AGENTS; BODY WEIGHT; DIBENZOTHIAZEPINES; ELECTRODES, IMPLANTED; FEVER; HEART RATE; INJECTIONS, INTRAVENTRICULAR; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; SYMPATHETIC NERVOUS SYSTEM;

EID: 33750284235     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2006.07.003     Document Type: Article

References (30)

1. Beuckmann C.T., and Yanagisawa M. Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation. J. Mol. Med. 80 (2002) 329-342
2. Bray G.A. Hypothalamic and genetic obesity: an appraisal of the autonomic hypothesis and the endocrine hypothesis. Int. J. Obes. 8 (1984) 119-137
3. Cannon B., and Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 84 (2004) 277-359
4. Chungh D.S., Kim B.N., and Cho S.C. Neuroleptic malignant syndrome due to three atypical antipsychotics in a child. J. Psychopharmacol. 19 (2005) 422-425
5. De Lecea L., Kilduff T.S., Peyron C., Gao X.B., Foye P.E., and Danielson P.E. The hypocretins: two hypothalamic peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA 95 (1998) 322-327
6. He J., Xu H., Yang Y., Zhang X., and Li X.M. Chronic administration of quetiapine alleviates the anxiety-like behavioural changes induced by a neurotoxic regimen of dl-amphetamine in rats. Behav. Brain Res. 160 (2005) 178-187
7. Holzer L., Paiva G., and Halfon O. Quetiapine-induced weight gain and escitalopram. Am. J. Psychiat. 162 (2005) 192-193
8. Kinkead B., Shahid S., Owens M.J., and Nemeroff C.B. Effects of acute and subchronic administration of typical and atypical antipsychotic drugs on the neurotensin system of the rat brain. J. Pharmacol. Exp. Ther. 295 (2000) 67-73
9. Kukkonen J.P., Holmqvist T., Ammoun S., and Akerman K.E. Functions of the orexinergic/hypocretinergic system. Am. J. Physiol. 283 (2002) C1567-C1591
10. Kuwahara M., Yayou K., Ishii K., Hashimoto S., Tsubone H., and Sugano S. Power spectral analysis of heart rate variability as a new method for assessing autonomic activity in the rat. J. Electrocardiol. 27 (1994) 333-337
11. Lubkin A., and Stricker-Krongrad A. Independent feeding and metabolic action of orexins in mice. Biochem. Biophys. Res. Commun. 253 (1998) 241-245
12. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., and Yanagisawa M. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435 (2001) 6-25
13. Monda M., Viggiano A., Mondola P., and De Luca V. Inhibition of prostaglandin synthesis reduces hyperthermic reactions induced by hypocretin-1/orexin A. Brain Res. 909 (2001) 68-74
14. Monda M., Viggiano A., and De Luca V. A paradoxical effect of orexin A: the hypophagia induced by hyperthermia. Brain Res. 961 (2003) 220-228
15. Monda M., Viggiano A., and De Luca V. Haloperidol reduces the sympathetic and thermogenic activation induced by orexin A. Neurosci. Res. 45 (2003) 17-23
16. Monda M., Viggiano An., Viggiano Al., Fuccio F., and De Luca V. Clozapine blocks the hyperthermia induced by orexin A in the rat. Physiol. Res. 53 (2004) 507-513
17. Monda M., Viggiano An., Viggiano Al., Viggiano E., Lanza A., and De Luca V. Hyperthermic reactions induced by orexin A: role of the ventromedial hypothalamus. Eur. J. Neurosci. 22 (2005) 1169-1175
18. Monda M., Viggiano A., Viggiano A., Viggiano E., and De Luca V. Risperidone potentiates the sympathetic and hyperthermic reactions induced by orexin A in the rat. Physiol. Res. 55 (2006) 73-78
19. Morrison S.F. Central pathways controlling brown adipose tissue thermogenesis. News Physiol. Sci. 19 (2004) 67-74
20. Nemeroff C.B., Kinkead B., and Goldstein J. Quetiapine: preclinical studies, phatmacokinetics, drug interactions, and dosing. J. Clin. Psychiat. 63 (2002) 5-11
21. Ness-Abramof R., and Apovian C.M. Drug-induced weight gain. Drugs Today 41 (2005) 547-555
22. Pellegrino L.J., Pellegrino A.S., and Cushman A.J. A Stereotaxic Atlas of the Rat Brain (1979), Plenum Press, New York
23. Ramaekers D., Beckers F., Demeulemeester H., and Aubert A.E. Cardiovascular autonomic function in conscious rats: a novel approach to facilitate stationary conditions. Ann. Noninvas. Electrocardiol. 7 (2002) 307-318
24. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., and Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92 (1998) 573-585
25. Samson W.K., Gosnell B., Chang J.K., Resch Z.T., and Murphy T.C. Cardiovascular regulatory actions of the hypocretins in brain. Brain Res. 831 (1999) 248-253
26. Shirasaka T., Nakazato M., Matsukura S., Takasaki M., and Kannan H. Sympathetic and cardiovascular actions of orexins in conscious rats. Am. J. Physiol. 277 (1999) R1780-R1785
27. Sweet D.C., Levine A.S., Billington C.I., and Kotz C.M. Feeding response to central orexins. Brain Res. 821 (1999) 535-538
28. Taheri S., Zeitzer J.M., and Mignot E. The role of hypocretins (orexins) in sleep regulation and narcolepsy. Annu. Rev. Neurosci. 25 (2002) 283-313
29. Van Den Pol A.N. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J. Neurosci. 19 (1999) 3171-3182
30. Zhang Z., Rickard J.F., Body S., Asgari K., Bradshaw C.M., and Szabadi E. Comparison of the effects of clozapine and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on progressive ratio schedule performance: evidence against the involvement of 5-HT1A receptors in the behavioural effects of clozapine. Psychopharmacology (Berl) 181 (2005) 381-391